SNR
     RDKit          3D

 15 16  0  0  0  0  0  0  0  0999 V2000
   -1.7780   -0.0266   -0.1453 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1279   -1.1736    0.2397 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0999   -0.8978    0.9591 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.1070    0.6411    1.0736 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.1084    1.0413    0.3895 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3902    1.1980    0.4368 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.8341    0.0099   -0.8468 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.3527   -1.3674    0.2150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7851    0.0411   -0.8289 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2354    2.6234   -0.0810 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9179    3.5937    1.0698 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9933    3.6217    2.1601 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3457    4.0162    1.6069 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8606    5.1424    2.1325 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9497    3.3700    0.7639 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  5  1  0
  1  9  2  0
  2  3  1  0
  3  4  1  0
  3  8  1  6
  4  5  1  6
  4  6  1  0
  6  7  1  0
  6 10  1  6
  7  8  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
M  END
>  <DRUGBANK_ID>  (1) 
DB02674

>  <SECONDARY_ACCESSION_NUMBERS>  (1) 
EXPT02932

>  <COMMON_NAME>  (1) 
4-(2-Oxo-Hexahydro-Thieno[3,4-D]Imidazol-4-Yl)-Butyricacid

$$$$
